OBJECTIVETo observe the effects of therapeutic method of expelling wind, eliminating phlegm and promoting blood circulation (EWEPPB) in treating acute cerebral infarction (ACI) depending on the clinical and data platform of stroke clinical unit.

METHODSACI patients were randomly assigned to the control group (36 cases) treated by routine Western therapy alone and the treatment group (32 cases) with routine therapy plus Chinese medicinal compound for EWEPPB. The treatment course was 14 days. The scores of TCM symptom, the NIH stroke scale (NIHSS), and Barthel index (BI) were used for evaluating the effect of treatment.

RESULTSThe scores of TCM symptom and NIHSS decreased, and that of BI increased after treatment in both groups, and the treatment in the treatment group showed a effect significantly better than that in the control group (P < 0.05).

CONCLUSIONEWEPPB is effective method in treating ACI, traditional Chinese compounds for EWEPPB could play a positive role in the stroke unit.

Adult ; Aged ; Aged, 80 and over ; Cerebral Infarction ; diagnosis ; drug therapy ; therapy ; Diagnosis, Differential ; Drugs, Chinese Herbal ; therapeutic use ; Female ; Humans ; Male ; Medicine, Chinese Traditional ; Middle Aged ; Phytotherapy ; Treatment Outcome

OBJECTIVETo explore the effect and mechanism on HBV replication in C gene truncated mutant.

METHODSProtein expression of C gene truncated vector and wild C gene vector were assay by SDS-PAGE Western blot. Constructed C gene truncated expression vector was cotransfected with wild HBV genome; virus load was detected by PCR in the culture medium and the cell. The formation of core particle was assay by Native western blot.

RESULTSThe recombinant vectors can efficiently express. Virus load of the cotransfected group by pcDNA3-deltaC and adwR9 was lower than that of control group in the culture medium and the cell. Protein band of the co-expressed group by pcDNA3-deltaC and pcDNA3-C showed slightly weaker than that of the co-expressed group by pcDNA3 and pcDNA3-C.

CONCLUSIONC gene truncated mutant could interfere with the formation of core particle and reduce of HBV replication

Cell Line ; Genetic Therapy ; Hepatitis B ; therapy ; Humans ; Mutation ; Transfection ; Viral Core Proteins ; genetics ; Virus Replication

Animals ; COS Cells ; Female ; Genetic Therapy ; Interleukin-12 ; genetics ; Liver Neoplasms, Experimental ; immunology ; therapy ; Mice ; Mice, Inbred BALB C ; T-Lymphocytes, Cytotoxic ; immunology

Objective To study the effect of passive motion from lower extremity on electromyography (EMG) activity of major muscles when the back under head down tilting state. Methods Thirty healthy subjects were selected. The EMGs of erector spinal and trapezius muscles were recorded and analyzed when human body was under head-down tilting at angel of 0°, 10°, 20° and 27° in static mode, respectively, in sway mode (along the axis of Z with frequencies of 120 and 140/min， respectively) and in vibration mode (along the axis of Y with frequency of 680/min) with the help of multifunctional test bed. Results In the static mode, the median frequency (MF) decreased with the increase of head-down titling angle; in the sway mode, the MF at each of 4 head-down tilting angles was smaller than that in the static mode. When the frequency was 120/min, the MF decreased with head-down tilting angle increasing, but when the frequency reached 140/min, the variation of MF became irregular. In the vibration mode, the MF increased with the increase of head-down tilting angle and was larger than that in the static mode. Conclusions In the static mode, the muscle fatigue increased with the head down tilting angle increasing; in the vibration mode, smaller head-down tilting angle should be selected to achieve better treatment effect; but in the sway mode, larger head-down tilting angle would be better, and the sway frequency should be set lower than 120/min to avoid potential damage due to excessive muscle fatigue.

Antiviral Agents/therapeutic use* ; Bibliometrics ; COVID-19/drug therapy* ; Drugs, Chinese Herbal/therapeutic use* ; Humans ; SARS-CoV-2

Objective: Several COVID-19 patients have overlapping comorbidities. The independent role of each component contributing to the risk of COVID-19 is unknown, and how some non-cardiometabolic comorbidities affect the risk of COVID-19 remains unclear. Methods: A retrospective follow-up design was adopted. A total of 1,160 laboratory-confirmed patients were enrolled from nine provinces in China. Data on comorbidities were obtained from the patients' medical records. Multivariable logistic regression models were used to estimate the odds ratio ( Results: Overall, 158 (13.6%) patients were diagnosed with severe illness and 32 (2.7%) had unfavorable outcomes. Hypertension (2.87, 1.30-6.32), type 2 diabetes (T2DM) (3.57, 2.32-5.49), cardiovascular disease (CVD) (3.78, 1.81-7.89), fatty liver disease (7.53, 1.96-28.96), hyperlipidemia (2.15, 1.26-3.67), other lung diseases (6.00, 3.01-11.96), and electrolyte imbalance (10.40, 3.00-26.10) were independently linked to increased odds of being severely ill. T2DM (6.07, 2.89-12.75), CVD (8.47, 6.03-11.89), and electrolyte imbalance (19.44, 11.47-32.96) were also strong predictors of unfavorable outcomes. Women with comorbidities were more likely to have severe disease on admission (5.46, 3.25-9.19), while men with comorbidities were more likely to have unfavorable treatment outcomes (6.58, 1.46-29.64) within two weeks. Conclusion Besides hypertension, diabetes, and CVD, fatty liver disease, hyperlipidemia, other lung diseases, and electrolyte imbalance were independent risk factors for COVID-19 severity and poor treatment outcome. Women with comorbidities were more likely to have severe disease, while men with comorbidities were more likely to have unfavorable treatment outcomes.
Adult ; Aged ; COVID-19/virology* ; China/epidemiology* ; Comorbidity ; Female ; Humans ; Male ; Middle Aged ; Retrospective Studies ; Severity of Illness Index ; Treatment Outcome